{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:32:17Z","timestamp":1771378337440,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.tice.2022.101805","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:42:04Z","timestamp":1650861724000},"page":"101805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach"],"prefix":"10.1016","volume":"76","author":[{"given":"Akram","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Jahanshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Oliveira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tice.2022.101805_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians","volume":"71","author":"Sung","year":"2021"},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16735-2","article-title":"A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities","volume":"11","author":"Narayan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2022.101805_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2016.02.042","article-title":"Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21WAF1\/CIP1 expression via epigenetic remodeling in LNCaP and PC3 cell lines","volume":"148","author":"Jadhav","year":"2016","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.tice.2022.101805_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cdd.4401389","article-title":"Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine","volume":"11","author":"Maeda","year":"2004","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.tice.2022.101805_bib5","first-page":"110","article-title":"The Impact of OPIUM and Its Derivatives on Cell Apoptosis and Angiogenesis","volume":"2","author":"Mirzaei","year":"2020","journal-title":"Transl. Res. Urol."},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/cancers12010108","article-title":"The application of arsenic trioxide in ameliorating ABT-737 target therapy on uterine cervical cancer cells through unique pathways in cell death","volume":"12","author":"Hsin","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/genes10010041","article-title":"Survivin splice variants in arsenic trioxide (As2O3)-Induced deactivation of PI3K and MAPK cell signalling pathways in MCF-7 cells","volume":"10","author":"Laka","year":"2019","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib8","first-page":"1","article-title":"Arsenic Trioxide (ATO), a novel therapeutic agent for prostate and bladder cancers","volume":"1","author":"Mirzaei","year":"2019","journal-title":"Transl. Res. Urol."},{"key":"10.1016\/j.tice.2022.101805_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.6-suppl_2-22","article-title":"Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies","volume":"6","author":"Murgo","year":"2001","journal-title":"oncologist"},{"issue":"47","key":"10.1016\/j.tice.2022.101805_bib10","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1038\/sj.onc.1208868","article-title":"Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway","volume":"24","author":"Scholz","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.tice.2022.101805_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.onc.1208192","article-title":"Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor \u03ba B","volume":"24","author":"Wei","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib12","first-page":"1","article-title":"Arsenic trioxide; a novel therapeutic agent for prostate and bladder cancers","volume":"1","author":"Mirzaei","year":"2019","journal-title":"Transl. Res. Urol."},{"issue":"7","key":"10.1016\/j.tice.2022.101805_bib13","doi-asserted-by":"crossref","first-page":"11206","DOI":"10.18632\/oncotarget.14493","article-title":"Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells","volume":"8","author":"Tai","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.tice.2022.101805_bib14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3892\/or.2016.4944","article-title":"Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells","volume":"36","author":"Zeng","year":"2016","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3892\/ol.2017.6205","article-title":"Antitumor effects of curcumin in human bladder cancer in vitro","volume":"14","author":"Shi","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2014.03.009","article-title":"Does bone marrow\u2013derived mesenchymal stem cell transfusion prevent antisperm antibody production after traumatic testis rupture?","volume":"84","author":"Aghamir","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.tice.2022.101805_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.123160","article-title":"Counteracting arsenic toxicity: Curcumin to the rescue?","volume":"400","author":"Bahrami","year":"2020","journal-title":"J. Hazard. Mater."},{"issue":"2","key":"10.1016\/j.tice.2022.101805_bib18","first-page":"116","article-title":"Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro","volume":"14","author":"Deng","year":"2008","journal-title":"Zhonghua Nan Ke Xue Natl. J. Androl."},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-4598-7-16","article-title":"Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis","volume":"7","author":"Shankar","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2022.101805_bib20","doi-asserted-by":"crossref","unstructured":"Ide H., Lu Y., Yamaguchi R., Muto S., Horie S. Chemopreventive potential of curcumin in prostate cancer. AACR; 2014.","DOI":"10.1158\/1538-7445.AM2014-226"},{"issue":"30","key":"10.1016\/j.tice.2022.101805_bib21","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","article-title":"Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer","volume":"35","author":"Yallapu","year":"2014","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.tice.2022.101805_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179587","article-title":"Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells","volume":"12","author":"Rivera","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tice.2022.101805_bib23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41388-020-01539-x","article-title":"VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk","volume":"40","author":"Kong","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.tice.2022.101805_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.yexcr.2009.11.020","article-title":"VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop","volume":"316","author":"Gonzalez-Moreno","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tice.2022.101805_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101684","article-title":"Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: an in-vitro study","volume":"74","author":"Mirzaei","year":"2022","journal-title":"Tissue Cell"},{"issue":"3","key":"10.1016\/j.tice.2022.101805_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00775-018-1537-9","article-title":"Arsenic trioxide: insights into its evolution to an anticancer agent","volume":"23","author":"Hoonjan","year":"2018","journal-title":"JBIC J. Biol. Inorg. Chem."},{"issue":"2","key":"10.1016\/j.tice.2022.101805_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031579","article-title":"Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and-independent human prostate cancer cells","volume":"7","author":"Chiu","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.110.168344","article-title":"Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines","volume":"335","author":"Sanchez","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.tice.2022.101805_bib29","first-page":"67","article-title":"The effect of herbal extracts on the treatment and prevention of prostate cancer: a literature review","volume":"1","author":"Mirzaei","year":"2019","journal-title":"Transl. Res. Urol."},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2008.03.025","article-title":"Curcumin and cancer: an \u201cold-age\u201d disease with an \u201cage-old\u201d solution","volume":"267","author":"Anand","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2022.101805_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/810423","article-title":"Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer","volume":"2013","author":"Bimonte","year":"2013","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1749-6632.2009.04731.x","article-title":"Effect of curcumin on nuclear factor \u03baB signaling pathways in human chronic myelogenous K562 leukemia cells","volume":"1171","author":"Reuter","year":"2009","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.tice.2022.101805_bib33","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.tice.2022.101805_bib34","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/pros.21383","article-title":"PC3 is a cell line characteristic of prostatic small cell carcinoma","volume":"71","author":"Tai","year":"2011","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.tice.2022.101805_bib35","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Invest. Urol."},{"issue":"10","key":"10.1016\/j.tice.2022.101805_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/pros.23177","article-title":"MiR\u2010301a regulates E\u2010cadherin expression and is predictive of prostate cancer recurrence","volume":"76","author":"Nam","year":"2016","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.tice.2022.101805_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4161\/cam.21687","article-title":"The role of Snail in prostate cancer","volume":"6","author":"Smith","year":"2012","journal-title":"Cell Adhes. Migr."},{"issue":"3","key":"10.1016\/j.tice.2022.101805_bib38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s13277-013-1253-6","article-title":"Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation","volume":"35","author":"Shang","year":"2014","journal-title":"Tumor Biol."},{"issue":"6","key":"10.1016\/j.tice.2022.101805_bib39","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1534\/g3.117.039909","article-title":"Whole-genome sequence of the metastatic PC3 and LNCaP human prostate cancer cell lines","volume":"7","author":"Seim","year":"2017","journal-title":"G3 Genes, Genomes Genetics"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816622000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816622000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:27:16Z","timestamp":1758572836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816622000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":39,"alternative-id":["S0040816622000775"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2022.101805","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2022.101805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101805"}}